Raffa Wealth Management’s Haemonetics HAE Stock Holding History

Raffa Wealth Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-18	Closed	-$724	–	569
2016 Q4	$724	Hold	18	–	–	﹤0.01%	562
2016 Q3	$652	Hold	18	–	–	﹤0.01%	597
2016 Q2	$522	Hold	18	–	–	﹤0.01%	669
2016 Q1	$630	Hold	18	–	–	﹤0.01%	586
2015 Q4	$580	Hold	18	–	–	﹤0.01%	619
2015 Q3	$582	Hold	18	–	–	﹤0.01%	596
2015 Q2	$744	Hold	18	–	–	﹤0.01%	488
2015 Q1	$809	Hold	18	–	–	﹤0.01%	463
2014 Q4	$674	Hold	18	–	–	﹤0.01%	510
2014 Q3	$629	Buy	+18	New	+$642	﹤0.01%	493
2014 Q1	–	Sell	-18	Closed	-$674	–	459
2013 Q4	$674	Buy	+18	New	+$741	﹤0.01%	510

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Raffa Wealth Management's HAE Position: Q1 2017 in Review

Raffa Wealth Management sold out of Haemonetics (HAE) in Q1 2017, closing a stake of 18 shares — an estimated $724 sold.

Raffa Wealth Management first reported a position in HAE in Q4 2013 and held it in 11 quarters. The position peaked at $809 in Q1 2015. 181 funds tracked by Wall St. Rank hold HAE as of Q1 2017.

Raffa Wealth Management reported no remaining Haemonetics position as of Q1 2017 after selling out during the quarter.
Raffa Wealth Management sold 18 Haemonetics shares in Q1 2017, an estimated $724.
Raffa Wealth Management first reported a position in Haemonetics in Q4 2013 and held it in 11 quarters.
Raffa Wealth Management's Haemonetics position peaked at $809 in Q1 2015.
181 funds tracked by Wall St. Rank held Haemonetics as of Q1 2017.

Based on Raffa Wealth Management's 13F filing for Q1 2017, filed 27 Jul 2026.